MDA5 (AL180) polyclonal, anti-mouse

Quantity: 50 µl

Description:
RIG-I and MDA5 are highly conserved helicases involved in the innate immune response to virus. MDA5, upon interaction with intracellular dsRNA (produced during viral replication), triggers a transduction cascade involving MAVS/IPS1, which results in the activation of NF-kappaB, IRF3 and IRF7 and the induction of the expression of antiviral cytokines such as IFN-beta and RANTES (CCL5). MDA5 is widely expressed at low levels. The expression is detected at higher levels in placenta, pancreas and spleen and barely in brain, testis and lung. Genetic variation in MDA5 is associated with diabetes mellitus insulin-dependent type 19 (IDDM19). A multifactorial disorder of glucose homeostasis that is characterized by susceptibility to ketoacidosis in the absence of insulin therapy.

Synonyms:
Helicard, Melanoma Differentiation-associated Gene 5

Isotype: Rabbit Polyclonal

Immunogen:
Recombinant mouse MDA5 (aa 2-208).

Form: Stabilized serum containing 0.02% sodium azide.

Specificity:
Recognizes mouse MDA5.

Reactivity: mouse

Applications: Immunohistochemistry, Western Blot

Working DIlution: Optimal conditions must be determined individually for each application.

Storage: 2-8C immediate use, or -20C (aliquoted)